← Leaderboards
Massimo T Pietropaolo
Children'S Hosp Pittsburgh/Upmc Hlth Sys
$14,169,309
Attributed
$14,169,309
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–20$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$14,169,309 · 4
By mechanism
R01$12,305,957 · 2
DP3$1,452,951 · 1
R21$410,401 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Pittsburgh/Upmc Hlth Sys
Same institution · by research overlap
- Marian G Michaels$11,056,283
- Dorothy J Becker$40,929,090
Others in their field
Top investigators on “Epidemiology”
- David Heimbrook · Leidos Biomedical Research, Inc.$390,770,069
- George R Seage · Abt Associates, Inc.$299,251,523
- Jeffrey P Krischer · University Of South Florida$264,076,260
- Barbara Driver · Westat, Inc.$221,167,491
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,739,528
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
EpidemiologyPreventAutoantibodiesNatural HistoryIsletAntibodiesBaseExhibitsInvestigationFirst Degree RelativeAntigensBiomarkerCollaborationsSamplingAutoantibodyResearch PersonnelEnrollmentFutureLaboratoriesAutoantigensAutoimmunityInsulin-Dependent Diabetes MellitusDiabetes MellitusHigh Risk
Grant awards (29)
ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES$690,960
R01 · FY2020 · DK · contact PI
ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES$717,641
R01 · FY2019 · DK · contact PI
ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES$716,158
R01 · FY2018 · DK · contact PI
ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES$668,366
R01 · FY2017 · DK · contact PI
Enhancement of Biomarkers for Type 1 Diabetes$538,754
R01 · FY2014 · DK · contact PI
Enhancement of Biomarkers for Type 1 Diabetes$28,542
R01 · FY2014 · DK · contact PI
A Novel Approach Applying CGM Metrics to Identify a Prediabetic State$1,310,306
DP3 · FY2013 · DK · contact PI
Enhancement of Biomarkers for Type 1 Diabetes$557,092
R01 · FY2013 · DK · contact PI
A Novel Approach Applying CGM Metrics to Identify a Prediabetic State$142,645
DP3 · FY2013 · DK · contact PI
Enhancement of Biomarkers for Type 1 Diabetes$582,540
R01 · FY2012 · DK · contact PI
Enhancement of Biomarkers for Type 1 Diabetes$581,572
R01 · FY2011 · DK · contact PI
Enhancement of Biomarkers for Type 1 Diabetes$736,066
R01 · FY2010 · DK · contact PI
Epidemiology of Heterogenity in Type 2 Diabetes$506,250
R01 · FY2009 · DK · contact PI
Epidemiology of Heterogenity in Type 2 Diabetes$572,737
R01 · FY2008 · DK · contact PI
Improving Prediction of IDDM$559,029
R01 · FY2007 · DK · contact PI
Epidemiology of Heterogenity in Type 2 Diabetes$517,205
R01 · FY2007 · DK · contact PI
Improving Prediction of IDDM$587,078
R01 · FY2006 · DK · contact PI
Epidemiology of Heterogenity in Type 2 Diabetes$519,535
R01 · FY2006 · DK · contact PI
Proteomics of Autoimmune Type 1 Diabetes$190,496
R21 · FY2006 · DK · contact PI
Improving Prediction of IDDM$527,152
R01 · FY2005 · DK
Epidemiology of Heterogenity in Type 2 Diabetes$487,361
R01 · FY2005 · DK
Proteomics of Autoimmune Type 1 Diabetes$219,905
R21 · FY2005 · DK
Improving Prediction of IDDM$586,238
R01 · FY2004 · DK
EPIDEMIOLOGY OF ISLET CELL AUTOIMMUNITY IN NIDDM$297,846
R01 · FY2003 · DK
EPIDEMIOLOGY OF ISLET CELL AUTOIMMUNITY IN NIDDM$304,436
R01 · FY2002 · DK
IMPROVING PREDICTION OF IDDM$247,847
R01 · FY2002 · DK
EPIDEMIOLOGY OF ISLET CELL AUTOIMMUNITY IN NIDDM$301,481
R01 · FY2001 · DK
IMPROVING PREDICTION OF IDDM$240,539
R01 · FY2001 · DK
IMPROVING PREDICTION OF IDDM$233,532
R01 · FY2000 · DK